These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6497402)

  • 21. Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
    Pavone-Macaluso M; Caramia G; Rizzo FP; Messana V
    Eur Urol; 1975; 1(1):53-6. PubMed ID: 786645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phase I study of an oral administration of VP 16-213].
    Ogawa M; Ota K; Oyama A; Fukuoka M; Takada M; Yoshida S; Sanpi K; Kimura I; Ohnoshi T; Kuraishi Y
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of VP-16-213 in non-small-cell lung cancer.
    Itri LM; Gralla RJ; Chapman RA; Kelsen DP; Casper ES; Golbey RB
    Am J Clin Oncol; 1982 Feb; 5(1):45-7. PubMed ID: 7081137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
    Aso Y; Ushiyama T; Suzuki K; Tajima A; Naide Y; Ohshima S; Matsuura O; Fukushima M; Ota K; Ono Y
    Nihon Gan Chiryo Gakkai Shi; 1988 May; 23(5):1046-51. PubMed ID: 3418215
    [No Abstract]   [Full Text] [Related]  

  • 25. Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
    Oishi N; Berenberg J; Blumenstein BA; Johnson K; Rivkin SE; Bukowski RM; O'Bryan RM; Stephens RL; Quagliana J; Saiers JH
    Cancer Treat Rep; 1987 Dec; 71(12):1307-8. PubMed ID: 3690547
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II trial of etoposide in advanced prostate cancer.
    Trump DL; Loprinzi CL
    Cancer Treat Rep; 1984 Sep; 68(9):1195-6. PubMed ID: 6478456
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
    Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
    Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
    [No Abstract]   [Full Text] [Related]  

  • 28. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
    Qazi R; Elson P; Khandekar JD
    Cancer Treat Rep; 1982 Feb; 66(2):405-6. PubMed ID: 7055823
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the anticancer effect of cisplatin and etoposide against nude mice transplanted urological malignant tumors].
    Gotoh A; Mizuno Y; Matsuwari S; Kitazawa S; Maeda S; Arakawa S; Kamidono S
    Gan To Kagaku Ryoho; 1994 May; 21(6):899-902. PubMed ID: 8185353
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy and radiotherapy for urological cancer].
    Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report].
    Takada T; Honda M; Momohara C; Komori K; Fujioka H
    Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.
    Cavalli F; Sonntag RW; Jungi F; Senn HJ; Brunner KW
    Cancer Treat Rep; 1978 Mar; 62(3):473-5. PubMed ID: 348319
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
    Sanz Ortíz J; Saiz García F
    Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy in urologic oncology].
    Deville JL
    Prog Urol; 2011 Nov; 21(11):816-21. PubMed ID: 22032608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple method for the administration of high-dose etoposide during autologous bone marrow transplantation.
    Lazarus HM; Creger RJ; Diaz D
    Cancer Treat Rep; 1986 Jun; 70(6):819-20. PubMed ID: 3524832
    [No Abstract]   [Full Text] [Related]  

  • 37. [Small cell carcinoma of the bladder: a case report].
    Hirai K; Sano H; Kita K; Mikata K; Ueki T; Fujikawa N; Kitami K; Hirokawa S
    Hinyokika Kiyo; 2005 Sep; 51(9):635-8. PubMed ID: 16229379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early phase II study of oral administration of etoposide for 21 consecutive days in patients with non-small-cell lung cancer].
    Hayasaka S; Kinuwaki E; Nakabayashi T; Saito R; Komatsu H; Nishikawa H; Ohizumi K; Shimizu T; Nakai Y; Niitani H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1367-1371. PubMed ID: 8821989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH; Johnson DE; Holoye PY; Samuels ML
    Cancer Treat Rep; 1977; 61(1):87-8. PubMed ID: 324624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.